Peptide Therapeutics Market: Growing Demand for Targeted Therapies Drives Industry Expansion
The global peptide therapies market was worth USD 42.05 billion in 2022 and is expected to increase at a CAGR of 6.3% from 2023 to 2030. During the forecast period, the rising prevalence of cancer and metabolic illnesses such as osteoporosis, obesity, and diabetes will boost the adoption of peptide therapies. Due to the growing number of paediatric patients and the prevalence of target diseases in low-income countries, there is a great demand for cost-effective medications. Peptide therapies are also being investigated as COVID-19 treatments, with researchers looking for molecules that can prevent the mechanisms involved in infection or treat the ensuing diseases.
Download Free Sample Report- https://www.marketdigits.com/request/sample/640
On February 21, 2020, the Food and Drug Administration expanded the scope of biologics, now encompassing chemically synthesized polypeptides comprising more than 40 but fewer than 100 amino acids, as well as synthetic peptides with 40 amino acids or less. This redefinition is poised to potentially enhance the market by opening up new avenues for peptide medications, particularly in the context of COVID-19 therapies.
The healthcare industry in the United States faced significant disruptions in clinical trials due to the COVID-19 pandemic. The widespread shift of drug research organizations to remote work settings resulted in the suspension of non-COVID-19-related trials. Consequently, during the global pandemic, the market for non-COVID-19 peptide therapies is expected to bear a greater impact.
- Increasing Prevalence of Chronic Diseases: The rising incidence of chronic conditions such as cancer, diabetes, and cardiovascular diseases is driving the demand for peptide therapeutics, which are often used in the development of targeted and personalized treatments.
- Advancements in Peptide Drug Discovery: Ongoing research and technological advancements in peptide drug discovery, including peptide engineering and formulation techniques, are accelerating the development of innovative peptide-based therapies.
- Biotechnology and Pharmaceutical Investments: Investments by biotechnology and pharmaceutical companies in peptide research and development are propelling the market forward. These companies are recognizing the potential of peptides as effective and safe therapeutic agents.
- Personalized Medicine Trends: Peptide therapeutics are well-suited for personalized medicine approaches due to their specificity and minimal side effects. As personalized medicine gains prominence, the demand for tailored peptide treatments is increasing.
- Emerging Peptide-Based COVID-19 Therapies: The COVID-19 pandemic has spurred research into peptide-based therapies as potential treatments or preventive measures. This has created new opportunities and interest in the development of antiviral peptides and vaccines.
Major Classifications are as follows:
Application Outlook (Revenue, USD Billion, 2023 - 2030)
• Cancer
• Metabolic Disorders
• Cardiovascular Disorders
• Respiratory Disorders
• Gastrointestinal Disorders
• Infectious Diseases
• Pain
• Dermatological Disorders
• Neurological Disorders
• Renal Disorders
• Others
Type Outlook (Revenue, USD Billion, 2023 - 2030)
• Generic
• Innovative
Type Of Manufacturers Outlook (Revenue, USD Billion, 2023 - 2030)
• In-house
• Outsourced
Route Of Administration Outlook (Revenue, USD Billion, 2023 - 2030)
• Parenteral Route
• Oral Route
• Pulmonary
• Mucosal
• Others
Synthesis Technology Outlook (Revenue, USD Billion, 2023 - 2030)
• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology
Regional Outlook (Revenue, USD Billion, 2023 - 2030)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Chile
• Middle East & Africa
• South Africa
• UAE
• Saudi Arabia
• Kuwait
Key Players
Eli Lilly and Company, Pfizer Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, Teva Pharmaceutical Industries Ltd., Sanofi, F. Hoffmann-La Roche Ltd, Novartis AG, Novo Nordisk A/S, GlaxoSmithKline plc., Ironwood Pharmaceuticals, Inc., Radius Health, Inc., and Ipsen Pharma.
Request for enquiry before buying- https://www.marketdigits.com/request/enquiry-before-buying/640
Key Questions Addressed by the Report
• What are the growth opportunities in the Peptide Therapeutics Market?
• What are the major raw materials used for manufacturing Peptide Therapeutics Market?
• What are the key factors affecting market dynamics?
• What are some of the significant challenges and restraints that the industry faces?
• Which are the key players operating in the market, and what initiatives have they undertaken over the past few years
Peptide Therapeutics Market Frequently Asked Questions (FAQs):
- What is the biggest limitation of peptide based drugs?
- Why are therapeutic peptides preferred over protein drugs?
- How do peptide therapeutics work?
- What are the advantages of peptide therapeutics over traditional drugs?
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact US:
1248 CarMia Way Richmond,
VA 23235, United States.
Phone: +1 510-730-3200
Email: sales@marketdigits.com
Website: https://www.marketdigits.com
Comments
Post a Comment